Germany is a visible actor in global health and a recognised anchor donor of Gavi, the Vaccine Alliance.

Under Chancellor Angela Merkel, Germany made global health a priority during both its G7 and G20 presidencies in 2015 (including hosting Gavi’s 2015 replenishment conference in Berlin) and 2017 respectively. In 2018, Germany partnered with Ghana and Norway to establish the “Global Action Plan for Healthy Lives and Well-Being for All (GAP),” bringing together Gavi and 12 other multilateral agencies to accelerate progress towards the health-related Sustainable Development Goals (SDGs). In October 2020, Germany launched a new government-wide global health strategy for 2020–2030, titled “Responsibility – Innovation – Partnership: Shaping Global Health Together,” to serve as the strategic basis for Germany’s engagement in global health.

As a Gavi donor since 2006, Germany contributes to Gavi through direct contributions via both the Federal Ministry for Economic Cooperation and Development (BMZ) and the KfW Development Bank. The 2013 Vaccine Summit in Abu Dhabi marked Germany’s first multi-year commitment to Gavi by a pledge of €90 million over 2013–2015. As patron of Gavi’s replenishment conference in Berlin in January 2015, Chancellor Merkel pledged €600 million for Gavi over the 2016–2020 strategic period – an impressive milestone in Germany’s history of support for the Vaccine Alliance.

In January 2020, as Gavi met in Davos to celebrate its 20th anniversary, Chancellor Merkel was the first world leader to pledge for Gavi’s 2021–2025 strategic period, announcing Germany’s commitment of another €600 million for 2021–2025. In September 2020, Germany confirmed a commitment of €100 million towards the Gavi COVAX AMC. A 2021 pledge to COVAX of €980 million placed Germany firmly among Gavi’s top donors.

In 2022, in line with its G7 Presidency priorities, Germany co-hosted the Gavi COVAX AMC Summit under the new federal government and Chancellor Scholz’s leadership, pledging an additional €400 million to the Gavi COVAX AMC. Germany also initiated Gavi’s work on the African Vaccine Manufacturing Accelerator (AVMA) under the G7 Presidency; and thanks to Federal Minister Svenja Schulze, Germany became a lead donor with US$ 318 million to AVMA and US$ 50 million to the First Response Fund at the launch in Paris on 20 June 2024.

Proceeds to Gavi from donor contributions & pledges (2021–2025) as of 30 June 2024

Proceeds are funds made available to Gavi from donor contributions and commitments, either through: cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm; or Advance Market Commitment (AMC) funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.

Contributions and pledges over time (US$ Millions)

Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data

Notes:
Direct Contributions (including Matching Fund)

Received contributions: non-US$ contributions for 2000–2023 and Q1-Q2 2024 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014–2023 and Q1-Q2 2024, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the applicable “forecast rates” from Bloomberg as of 30 June 2024 or using the rates applicable to any hedge agreement in place.

Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ direct contribution and Gavi Matching Fund pledges for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents using the “spot rates” from Refinitiv as at 30 June 2024 or using the rates applicable to any hedge agreement in place.

IFFIm contributions

Received contributions: non-US$ contributions for 2000–2023 and for Q1-Q2 2024 are expressed in US$ equivalents as confirmed by the World Bank Group’s International Bank for Reconstruction and Development (IBRD).

Future contributions: non-US$ contributions for Q3-Q4 2024 and for years 2025 and beyond are expressed in US$ equivalents as follows:

  • for signed contribution agreements, contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements; and
  • for contribution agreements not yet signed, contributions are expressed in US$ equivalents using the applicable “spot rates” from Refinitiv as of 30 June 2024.

General notes regarding IFFIm contributions:

Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
 
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the donor’s amount due, in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund (IMF). Since 29 June 2021, no reduction applies, as all countries from the reference portfolio have cleared their arrears with the IMF.

All donors

Subscribe to our newsletter